Therapeutic treatment of chromatinopathies
Номер патента: EP4121166A1
Опубликовано: 25-01-2023
Автор(ы): Alessandra Fasciani, Alessio Zippo
Принадлежит: Universita degli Studi di Trento
Опубликовано: 25-01-2023
Автор(ы): Alessandra Fasciani, Alessio Zippo
Принадлежит: Universita degli Studi di Trento
Реферат: The invention relates to a novel therapeutic treatment of chromatinopathies. Compounds selected from inhibitors of the Ataxia Telangiectasia and Rad3 -related (ATR) protein and inhibitors of the Chk1 protein were found to be effective in the therapeutic treatment of a chromatinopathy preferably selected from Kabuki Syndrome (KS), Kabuki Syndrome 2 (KS 2), Charge Syndrome (CS), Rubinstein-Taybi syndrome (RT) and Cornelia de Lange syndrome (CdL).
Therapeutic treatment of chromatinopathies
Номер патента: CA3171970A1. Автор: Alessio Zippo,Alessandra Fasciani. Владелец: Universita degli Studi di Trento. Дата публикации: 2021-09-23.